Viewing Study NCT06228066


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-27 @ 8:06 AM
Study NCT ID: NCT06228066
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2024-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 10001523
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators